StockData
Guardant Health, Inc. logo

Guardant Health, Inc. (GH) stock

GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$145.14+1.86 (+1.30%)

Close on Nov 18, 2026Market cap $19.48BP/E –Yield –

Guardant Health free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Guardant Health's free cash flow for the twelve months ending Jun 30, 2026 was -$240.72M. For fiscal 2025 it was -$233.07M. The highest annual figure on record is -$38.48M in fiscal 2016.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$233.07M–
FY2024Dec 31, 2024-$274.94M–
FY2023Dec 31, 2023-$345.46M–
FY2022Dec 31, 2022-$386.92M–
FY2021Dec 31, 2021-$284.05M–
FY2020Dec 31, 2020-$140.10M–
FY2019Dec 31, 2019-$65.85M–
FY2018Dec 31, 2018-$92.39M–
FY2017Dec 31, 2017-$78.92M–
FY2016Dec 31, 2016-$38.48M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$69.54M–
Q1 FY2026Mar 31, 2026-$71.20M–
Q4 FY2025Dec 31, 2025-$54.22M–
Q3 FY2025Sep 30, 2025-$45.76M–
Q2 FY2025Jun 30, 2025-$65.93M–
Q1 FY2025Mar 31, 2025-$67.15M–
Q4 FY2024Dec 31, 2024-$83.39M–
Q3 FY2024Sep 30, 2024-$55.26M–
Q2 FY2024Jun 30, 2024-$99.08M–
Q1 FY2024Mar 31, 2024-$37.22M–
Q4 FY2023Dec 31, 2023-$82.81M–
Q3 FY2023Sep 30, 2023-$80.16M–
Q2 FY2023Jun 30, 2023-$100.53M–
Q1 FY2023Mar 31, 2023-$81.97M–
Q4 FY2022Dec 31, 2022-$100.75M–
Q3 FY2022Sep 30, 2022-$99.89M–
Q2 FY2022Jun 30, 2022-$134.97M–
Q1 FY2022Mar 31, 2022-$51.32M–
Q4 FY2021Dec 31, 2021-$101.61M–
Q3 FY2021Sep 30, 2021-$75.29M–
Q2 FY2021Jun 30, 2021-$81.27M–
Q1 FY2021Mar 31, 2021-$25.88M–
Q4 FY2020Dec 31, 2020-$66.51M–
Q3 FY2020Sep 30, 2020-$17.84M–
Q2 FY2020Jun 30, 2020-$32.87M–
Q1 FY2020Mar 31, 2020-$22.88M–
Q4 FY2019Dec 31, 2019-$37.43M–
Q3 FY2019Sep 30, 2019-$4.53M–
Q2 FY2019Jun 30, 2019-$16.88M–
Q1 FY2019Mar 31, 2019-$7.01M–
Q4 FY2018Dec 31, 2018-$29.47M–
Q3 FY2018Sep 30, 2018-$27.96M–
Q2 FY2018Jun 30, 2018-$24.38M–
Q1 FY2018Mar 31, 2018-$10.58M–
Q4 FY2017Dec 31, 2017-$20.95M–

More Guardant Health figures

See a number that looks wrong?